跳至主要内容
临床试验/NCT02133989
NCT02133989Unknown3 期

Ticlopidine+Ginkgo Biloba Versus Clopidogrel in Clopidogrel Resistant Patients Undergoing Cartoid Artery Stent Placement

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2014年6月最近更新:
适应症
干预措施

试验速览

阶段
3 期
入组人数
86
试验地点
1
主要终点
New ischemic lesion on diffusion-weighted imaging (DWI)

研究概览

简要总结

The purpose of this study is to evaluate the efficacy and safety of the ticlopidine + ginko biloba compared to clopidogrel in clopidogrel resistant patients undergoing carotid artery stent placement. The investigators hypothesized that ticlopidine + ginko biloba is superior than clopidogrel in terms of post-stent ischemic lesions in these patients without serious complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for stent implantation due to carotid stenosis
  • Patients resistant to clopidogrel defined by platelet inhibition rate <20% measured by Verify Now before carotid stenting
  • Patients with informed consent

排除标准

  • Antiplatelet therapy other than aspirin, clopidogrel, or ticlopidine
  • Unable to perform MRI scans
  • Patients with hematologic abnormalities including neutrophil <1500/ul, platelet <100,000/uL, or AST/ALT >120 U/L
  • Unsuitable for participation

研究组 & 干预措施

Ticlopidine+Ginko biloba

Experimental

Switch to ticlopidine + ginko biloba

干预措施: Ticlopidine + Ginko biloba (Drug)

Clopidogrel

Active Comparator

Keep clopidogrel

干预措施: Clopidogrel (Drug)

结局指标

主要结局

New ischemic lesion on diffusion-weighted imaging (DWI)

时间窗: within 24 hours after carotid stenting

Presence of new ischemic lesion in the ipsilesioinal hemisphere on DWI after carotid stening

次要结局

  • Number and Volume of new ischemic lesions on DWI(within 24 hours after carotid stenting)
  • Benign and malignant microembolic signals (MES) on transcranial Doppler (TCD)(within 24 hours after carotid stenting)
  • Ischemic stroke or transient ischemic attack (TIA)(within 30 days after carotid stenting)
  • Change of clopidogrel resistance(1 day after carotid stenting)
  • Pucture site hematoma(within 30 days after carotid stenting)
  • Mycocardial infarction(within 30 days after carotid stenting)
  • Death(within 30 days after carotid stenting)
  • Hematological abnormalities(within 30 days after carotid stenting)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Oh Young Bang

MD

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验